Literature DB >> 22569230

Emerging trends in the stabilization of amorphous drugs.

Riikka Laitinen1, Korbinian Löbmann, Clare J Strachan, Holger Grohganz, Thomas Rades.   

Abstract

The number of active pharmaceutical substances having high therapeutic potential but low water solubility is constantly increasing, making it difficult to formulate these compounds as oral dosage forms. The solubility and dissolution rate, and thus potentially the bioavailability, of these poorly water-soluble drugs can be increased by the formation of stabilized amorphous forms. Currently, formulation as solid polymer dispersions is the preferred method to enhance drug dissolution and to stabilize the amorphous form of a drug. The purpose of this review is to highlight emerging alternative methods to amorphous polymer dispersions for stabilizing the amorphous form of drugs. First, an overview of the properties and stabilization mechanisms of amorphous forms is provided. Subsequently, formulation approaches such as the preparation of co-amorphous small-molecule mixtures and the use of mesoporous silicon and silica-based carriers are presented as potential means to increase the stability of amorphous pharmaceuticals.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amorphous drug; Co-amorphous; Dissolution; Mesoporous; Solubility; Stability

Mesh:

Substances:

Year:  2012        PMID: 22569230     DOI: 10.1016/j.ijpharm.2012.04.066

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  35 in total

1.  Processability of AquaSolve™ LG polymer by hot-melt extrusion: Effects of pressurized CO2 on physicomechanical properties and API stability.

Authors:  Mashan Almutairi; Bjad Almutairy; Sandeep Sarabu; Ahmed Almotairy; Eman Ashour; Suresh Bandari; Amol Batra; Divya Tewari; T Durig; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2019-04-18       Impact factor: 3.981

2.  Elucidation of Compression-Induced Surface Crystallization in Amorphous Tablets Using Sum Frequency Generation (SFG) Microscopy.

Authors:  Pei T Mah; Dunja Novakovic; Jukka Saarinen; Stijn Van Landeghem; Leena Peltonen; Timo Laaksonen; Antti Isomäki; Clare J Strachan
Journal:  Pharm Res       Date:  2016-10-13       Impact factor: 4.200

3.  Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory.

Authors:  Conor Donnelly; Yiwei Tian; Catherine Potter; David S Jones; Gavin P Andrews
Journal:  Pharm Res       Date:  2014-07-30       Impact factor: 4.200

Review 4.  Hot-Melt Extrusion: a Roadmap for Product Development.

Authors:  Marta F Simões; Rui M A Pinto; Sérgio Simões
Journal:  AAPS PharmSciTech       Date:  2021-06-17       Impact factor: 3.246

5.  Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters.

Authors:  Shu Li; Yiwei Tian; David S Jones; Gavin P Andrews
Journal:  AAPS PharmSciTech       Date:  2016-01-04       Impact factor: 3.246

6.  New Perspectives for Fixed Dose Combinations of Poorly Water-Soluble Compounds: a Case Study with Ezetimibe and Lovastatin.

Authors:  Manoela K Riekes; Axel Engelen; Bernard Appeltans; Patrick Rombaut; Hellen K Stulzer; Guy Van den Mooter
Journal:  Pharm Res       Date:  2016-02-08       Impact factor: 4.200

7.  The Investigation of Flory-Huggins Interaction Parameters for Amorphous Solid Dispersion Across the Entire Temperature and Composition Range.

Authors:  Yiwei Tian; Kaijie Qian; Esther Jacobs; Esther Amstad; David S Jones; Lorenzo Stella; Gavin P Andrews
Journal:  Pharmaceutics       Date:  2019-08-19       Impact factor: 6.321

8.  Formulation of gammaoryzanol-loaded nanoparticles for potential application in fortifying food products.

Authors:  Serveh Ghaderi; Saeed Ghanbarzadeh; Zahra Mohammadhassani; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2014-12-31

9.  The effect of polymeric excipients on the physical properties and performance of amorphous dispersions: Part I, free volume and glass transition.

Authors:  Jinjiang Li; Junshu Zhao; Li Tao; Jennifer Wang; Vrushali Waknis; Duohai Pan; Mario Hubert; Krishnaswamy Raghavan; Jatin Patel
Journal:  Pharm Res       Date:  2014-08-09       Impact factor: 4.200

10.  Influence of Copolymer Composition on In Vitro and In Vivo Performance of Celecoxib-PVP/VA Amorphous Solid Dispersions.

Authors:  Matthias Manne Knopp; Julia Hoang Nguyen; Huiling Mu; Peter Langguth; Thomas Rades; René Holm
Journal:  AAPS J       Date:  2016-01-14       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.